Notice of Results

RNS Number : 6999J
Hutchison China Meditech Limited
05 July 2011
 



 

 

 

 

Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

 

 

Notice of Announcement of 2011 Interim Results

 

 

London: Tuesday, 5 July 2011: Chi-Med will be announcing its interim results for the six months ended 30 June 2011 on Monday, 1 August 2011.

 

 

Ends

 

 

Enquiries

 

    Chi-Med

    Christian Hogg, CEO

Telephone: +852 2121 8200



    Citigate Dewe Rogerson

    Anthony Carlisle

    David Dible

Telephone: +44 (0) 20 7638 9571

Mobile: +44 (0) 7973 611 888

Mobile: +44 (0) 7967 566 919

 

    Lazard & Co., Limited

    Paul Gismondi

    Nick Fowler

Telephone: +44 (0) 20 7187 2000

 

 

 


About Chi-Med

 

Chi-Med is the holding company of a healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006.  It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.

 

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORDMGGNGDGGMZM
UK 100

Latest directors dealings